Hyperuricemia: Clinical Trials

3 trials for Hyperuricemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Recruiting 3
Phase 21Recruiting 1

Follow Hyperuricemia: new trials by email Literature Review of Hyperuricemia trials Research Report on Hyperuricemia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of IN026 in Participants With Refractory Gout
IN026 Injection - Refractory Gout
Phase 1RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology162026-06-122026-07-31
A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
IG3018, Placebo matching IG3018 - Hyperuricemia, Hypouricemia, Renal
Phase 1 / Phase 2RecruitingIntelligem Therapeutics Australia Pty Ltd.602024-11-122026-02-03
Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia
Pegylated Recombinant Candida Utilis Uricase for Injection - Gout, Hyperuricemia
Phase 1RecruitingShenyang Sunshine Pharmaceutical Co., LTD.602023-11-202025-05-28

Narrower conditions

Gout (2)  ·  Metabolic Diseases (1)  ·  Renal Insufficiency, Chronic (1)  ·  Renal hypouricemia (1)  ·  Rheumatic Diseases (1)

Broader conditions

Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Arthritis (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Crystal Arthropathies (2)  ·  Genetic Diseases, Inborn (2)  ·  Joint Diseases (2)  ·  Metabolism, Inborn Errors (2)  ·  Musculoskeletal Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Purine-Pyrimidine Metabolism, Inborn Errors (2)  ·  Chronic Disease (1)  ·  Connective Tissue Diseases (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)

Interventions

Injections (1)

Sponsors

Intelligem Therapeutics Australia Pty Ltd. (1)  ·  Shenyang Sunshine Pharmaceutical Co., LTD. (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

China (2)  ·  Australia (1)  ·  Taiwan (1)

Top investigators

QiuBai Li (1)